Evidence map›Paper›PMID 39699809›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Induction on Insulin Resistance In Vitro.

Eng Leng Saw

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Eng Leng SawWhitaker Cardiovascular Institute, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. elsaw@bu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular model serves as a crucial preclinical research tool, providing essential insights into the mechanistic aspects of disease biology. Particularly in the study of chronic metabolic disorders such as type 2 diabetes mellitus and obesity, palmitate (a saturated fatty acid) is often used as a key inducer of insulin resistance in vitro. Within this chapter, I delineate procedures aimed at inducing insulin resistance in AC16 human cardiac-derived cells. The method involves the strategic application of heightened concentrations of palmitate and glucose to specifically target the AKT/GLUT-4 signaling pathway.

Indexed as

GlucoseInsulin ResistanceProto-Oncogene Proteins c-aktSignal TransductionCell LineGlucose Transporter Type 4HumansInsulinMyocytes, CardiacPalmitatesGlucoseGlucose Transporter Type 4InsulinPalmitatesProto-Oncogene Proteins c-aktAC16 human cardiac-derived cellsAKTGlucoseGLUT-4Insulin resistancePalmitate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.